(Q73414301)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166881%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Ensuring vaccine safety in immunization programmes--a WHO perspective (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166881%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

1 reference

L Jodar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166881%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P Duclos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166881%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J B Milstien

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166881%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

E Griffiths

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166881%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M T Aguado

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166881%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C J Clements

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166881%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166881%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166881%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166881%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

13-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166881%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1594-1605

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166881%20AND%20SRC:MED&resulttype=core&format=json

Acquired immunodeficiency syndrome in Romania

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Risk Factors Associated with a High Seroprevalence of Hepatitis C Virus Infection in Egyptian Blood Donors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Epidemiology of needlestick injuries in house officers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Underreporting of needlestick injuries in a university hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Thiomersal in vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Measles vaccination in India and controversies regarding adverse reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Occurrence of suppurative lymphadenitis after a change of BCG vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

BCG-associated adenitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Outbreak of Bacillus Calmette-Guérin-associated lymphadenitis and abscesses in Jamaican children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Development and clinical application of new polyvalent combined paediatric vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Combination vaccines consisting of acellular pertussis vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Pulsed controlled-released system for potential use in vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

An outbreak of hepatitis B associated with jet injections in a weight reduction clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Immunogenicity of new virosome influenza vaccine in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

1 reference

7 January 2021

Expression of hepatitis B surface antigen in transgenic plants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Immunogenicity of transgenic plant-derived hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Oral immunization with a recombinant bacterial antigen produced in transgenic plants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Optimism over vaccines administered via mucosal surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Skin immunization made possible by cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Contamination of poliovirus vaccine with SV40 and the incidence of medulloblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Examination of poliovirus vaccine preparations for SV40 sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Assessing the significance of reverse transcriptase activity in chick cell-derived vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Vaccine adverse events: causal or coincidental?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

Autism, inflammatory bowel disease, and MMR vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900358-3

7 January 2021

10.1016/S0264-410X(00)00358-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166881%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference